SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-055005
Filing Date
2023-10-25
Accepted
2023-10-25 08:03:53
Documents
14
Period of Report
2023-10-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rani-20231025.htm   iXBRL 8-K 46880
2 EX-99.1 rani-ex99_1.htm EX-99.1 12909
3 GRAPHIC img125106939_0.jpg GRAPHIC 5250
  Complete submission text file 0000950170-23-055005.txt   191426

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rani-20231025_pre.xml EX-101.PRE 10303
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rani-20231025_lab.xml EX-101.LAB 14018
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rani-20231025.xsd EX-101.SCH 2493
8 EXTRACTED XBRL INSTANCE DOCUMENT rani-20231025_htm.xml XML 4939
Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Filer) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40672 | Film No.: 231344029
SIC: 2834 Pharmaceutical Preparations